'Will roll out vaccine as early as possible': Bharat Biotech on COVAXIN
Video Credit: ANI - Duration: 01:12s - Published
'Will roll out vaccine as early as possible': Bharat Biotech on COVAXIN
While addressing a press conference via video conferencing in Hyderabad on January 04, the Chairman and Managing Director (MD) of Bharat Biotech International Limited, Dr Krishna M Ella explained meaning of the phrase 'restricted use in emergency situation in clinical trial mode'.
Ella said, "No placebo.
We keep vaccinating the people at an open level and then monitor the safety and efficacy.
That is what it means in our project mode method in emergency license." "We will roll out the vaccine as early as possible.
Batches have been sent to Kasauli government testing lab already."
Andhra Pradesh and Telangana played a significant role in India surpassing China as the top source of international students in the US for the 2023-24 academic.. IndiaTimes
Evernorth, the healthcare arm of Cigna Group, inaugurated its first global innovation hub outside the US in Hyderabad. The hub, slated to be Evernorth's largest,.. IndiaTimes
A minor explosion occurred near a temple in Hyderabad's Mailardevpally area on Monday, injuring a man cleaning garbage nearby. The man, who also performs rituals.. IndiaTimes
Bharat Biotech has said that the probable cause of death of a 42-year-old volunteer was cardio... DNA - Published Also reported by •Mid-Day •IndiaTimes
Tamil Nadu health minister C Vijayabaskar voluntarily took the vaccine Covaxin at Rajiv Gandhi Government General Hospital in Chennai. Vijayabaskar, who is a doctor and a member of the IMA, had earlier..
Credit: HT Digital Content Duration: 02:14Published
The Health and Family Welfare Minister of Tamil Nadu, Dr C Vijayabaskar took Bharat Biotech's Covaxin shot. He took the shot in Chennai on morning of January 22. Dr C Vijayabaskar requested all to get..
Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based..